| Volume: | 107,048 |
|---|---|
| Day's Low: | $32.30 |
| 52-wk Low: | $15.64 |
| Previous Close: | $32.60 |
| Dividend: | $0.08 |
| Market Cap: | 2,651,600 |
| Avg Volume: | 751,200 |
|---|---|
| Day's High: | $32.84 |
| 52-wk High: | $34.44 |
| Open Price: | $32.66 |
| Yield: | 0.00% |
| P/E (Forward): | 15.31 |
| 8:44 AM | 11/2/2009 | GlaxoSmithKline, Valeant File Retigabine New Drug Application |
| 8:36 AM | 11/2/2009 | Meda: Retigabine Applications Filed In US, Europe |
| Most Recent Quarter ($) | Same Quarter Last Year ($) | % Change | |
| EPS, Pro Forma | 0.58 | 0.11 | 427.27 |
| EPS, GAAP | 0.44 | 2.35 | -81.28 |
| Consensus Estimate | 0.49 | 0.18 | 172.22 |
| Trailing 12 Months | Year-Earlier Period | % Change | |
| EPS, Pro Forma | 2.07 | 0.82 | 152.44 |
| EPS, GAAP | 1.49 | 1.42 | 4.93 |
| Consensus Estimate | 1.45 | NA | NA |
| VRX | Industry Average | |
| P/E (TTM) | 21.88 | 82.10 |
| P/E (Forward) | 15.31 | 1.20 |
| PEG Ratio | 1.03 | 0.08 |
| Price/Sales | 3.54 | 3.90 |
| Beta | 0.51 | 0.47 |